# When someone wants to stop taking a medicine **What this article is about.** For an adult who wants to discuss stopping a prescribed medicine because of unwanted effects, cost, doubts about benefit, improvement in their condition or weariness with treatment. How to prepare a shared decision with a doctor, find support and distinguish an ordinary review from a situation needing urgent help. This article provides no universal discontinuation plan. ## The next step depends on the current situation Suspected poisoning, difficulty breathing, loss of consciousness or seizures require immediate local emergency medical help. Do not wait for a scheduled appointment, an exact explanation of what happened or completed notes. An ordinary discussion about stopping treatment does not replace help for acute danger. [NHS, Poisoning](https://www.nhs.uk/conditions/poisoning/) If there is no acute danger, the next step is to contact the prescriber or another accessible medical service able to review this particular treatment. You might say: “I would like to discuss stopping this medicine. This is what worries me, but I also see this benefit. Which options fit my situation, and who can support the decision?” This wording does not guarantee agreement or quick access; it makes the purpose of the conversation clear. You do not first need to test yourself by missing treatment, stopping it or making your sleep worse. Wanting a treatment change can be discussed without shame or proof of your independence. ## Wanting to stop and a diagnosis are different questions Reasons can coexist. A medicine helps, but unwanted effects affect relationships; you feel better, but do not know how much longer support is needed; the price is unaffordable although the effect is useful. You need not resolve that tension before asking for help. The NHS describes antidepressant benefits and unwanted effects, and the need to discuss stopping with a doctor. This concerns a particular medicine group rather than every prescription. [NHS, Antidepressants](https://www.nhs.uk/medicines/antidepressants/) Physical adaptation to some medicines can produce withdrawal symptoms when taking them is reduced or stopped; tolerance means a weakening of the previous effect. Addiction involves impaired control and continued use despite harm, rather than these phenomena alone. The MHRA distinguishes these concepts in information about benzodiazepines, Z-drugs and gabapentinoids. This does not mean every long-term treatment causes addiction or that all medicines have the same withdrawal effects. Wanting to stop, fearing discontinuation and remaining able to work also neither establish a diagnosis nor prove safety. [MHRA, information about the specified groups](https://www.gov.uk/drug-safety-update/improving-information-supplied-with-gabapentinoids-pregabalin-slash-gabapentin-benzodiazepines-and-z-drugs) ## What a shared decision means A medical review considers the particular medicine, condition, treatment history, benefit, unwanted effects and your goals. For example, RCPsych explains that continuing an antidepressant can be justified by the course of the illness, while stopping requires an individual discussion. Useful continuation is not a moral failure; it also does not imply compulsory lifelong treatment for everyone. [RCPsych, Stopping antidepressants](https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants) The conversation may concern continuing with review, changing the prescription or stopping with appropriate support. These possibilities are not a list of actions to choose independently. A friend's experience with a different medicine does not replace an assessment of your treatment. It helps to ask why the doctor proposes a particular option, what remains uncertain and when the decision should be reconsidered. If your goals differ, you can ask for an explanation or another accessible medical opinion. Sharing the decision does not require silent agreement, and an informal suggestion does not become a medical assessment. ## Four optional fields for the conversation Prepare only information you already know. This is not a test, diagnostic form or condition for obtaining help. You do not have to reconstruct your entire history or run a new experiment; any field can be left blank. 1. **Prescription and purpose.** Which medicine was prescribed and why, and who manages treatment, as far as you know. 2. **Benefit and difficulty.** What helps and what causes difficulties; why the wish to change treatment has arisen now. 3. **Changes that have already occurred.** What is known about changes to the prescription and your condition. Do not present a possible cause as proven. 4. **Desired decision and support.** What you want to discuss, whom you can contact and what manageable help you need to make contact. At the appointment you might ask: “Who is responsible for the medical review? How can I get in touch if my condition changes? Which changes require urgent help with my particular treatment? What happens if the designated professional is unavailable?” There is no single answer for all medicines and conditions. Written questions support a conversation; they are not treatment. ## If the previous doctor is unavailable A waiting list, cost, language or a change of clinician can leave someone without clear support. These are real obstacles. Ask who can assess the prescription and what help is available before that review. A pharmacist may help clarify information about the particular medicine and an available route to care; a conversation with a psychologist does not replace medical assessment of a medicine change. If access to your prescribed medicine worries you, tell the medical service directly rather than substituting it or changing how you take it yourself. Not every service has the relevant authority; availability and cost need to be checked locally. SAMHSA suggests preparing questions about appointments, waiting and access conditions. These questions help with a first contact but do not confirm that treatment has begun. [SAMHSA, How to Set Up an Appointment](https://www.samhsa.gov/find-support/health-care-or-support/how-to-set-up-an-appointment) ## A dangerous reaction needs a different level of decision Planned discussion and an acute reaction cannot be combined into one rule such as “withdraw gradually” or “always continue.” For example, the FDA warns about complex behaviour while not fully awake with certain Z-drugs, including actions a person does not later remember. If this happens, immediate contact with a medical professional is needed for an urgent decision about further treatment and use. It should not wait for an ordinary appointment, and it is not a reason to repeat use to test your memory. Immediate danger requires emergency help. [FDA, risks of certain Z-drugs](https://www.fda.gov/consumers/consumer-updates/taking-z-drugs-insomnia-know-risks) This example does not apply to every medicine. How to respond to a particular deterioration depends on the medicine and the person's condition; this article provides no instructions for stopping, restarting, replacing or changing an amount. Immediate threats to safety do not require first settling an argument about whether this is “addiction.” ## Support and the right to reconsider After the medical discussion, clarify what decision was reached, who supports it, which contact is available and what requires another consultation. If deterioration or a new unwanted effect has already occurred, report known facts to the professional without testing the cause by stopping or restarting on your own. Routine consultation and urgent help have different purposes. A close adult may, with your consent, help organise contact or share a fact they observed. They do not have to control medicines and do not become solely responsible for treatment. Children must not be assigned to monitor an adult's medicine use, breathing, sleep or mood. Protecting people harmed by threats or violence matters in its own right. The supporter's own help and rest matter too. [SAMHSA, Caring for Yourself](https://www.samhsa.gov/find-support/helping-someone/caring-for-yourself) Doubts do not close the door to help. Family love, a sense of purpose and a supportive environment can support a person, but do not replace an individual medical decision or become prerequisites for it. ## Sources and limits Content checked: 14 October 2026, Asia/Bangkok. Precise parts of primary sources previously personally read were reused after checking saved entries and hashes. This is a complete practical article rather than an individual prescription, diagnosis or confirmation of local availability. UK and US information does not establish legal status or services in Russia or Thailand. - [NHS, Poisoning](https://www.nhs.uk/conditions/poisoning/) — last reviewed 12 June 2025; the author's verified reading of the main page and date. Urgent-help orientation without UK telephone numbers or home procedures. - [NHS, Antidepressants](https://www.nhs.uk/medicines/antidepressants/) — last reviewed 12 June 2025; the author's verified main-text reading. Benefit, unwanted effects and discontinuation within this group, not every medicine leaflet or underlying trial. - [MHRA, Improving Information Supplied with Gabapentinoids, Benzodiazepines and Z-Drugs](https://www.gov.uk/drug-safety-update/improving-information-supplied-with-gabapentinoids-pregabalin-slash-gabapentin-benzodiazepines-and-z-drugs) — 8 January 2026; the author's verified reading of the main communication, conceptual distinctions and review boundaries. Linked NICE material and withdrawal protocols not used. The author's reading showed the OGLv3 footer with exceptions; the full licence returned 403 and is not claimed as read. - [Royal College of Psychiatrists, Stopping antidepressants](https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants) — March 2024; the author's verified reading of selected explanations and date metadata. Not all 447 lines, tables or an individual plan; no reproduction of source-labelled NICE guidance. - [SAMHSA, How to Set Up an Appointment](https://www.samhsa.gov/find-support/health-care-or-support/how-to-set-up-an-appointment) — 24 April 2023; the author's verified reading of the complete displayed official expanded text; direct HTML returned 403. Access questions rather than a service guarantee. - [FDA, Taking Z-drugs for Insomnia? Know the Risks](https://www.fda.gov/consumers/consumer-updates/taking-z-drugs-insomnia-know-risks) — the author's verified main-communication reading. Substantive revision date not established in displayed text. Particular Z-drugs and urgent clinical contact, not worldwide approval or the entire research base. - [SAMHSA, Caring for Yourself](https://www.samhsa.gov/find-support/helping-someone/caring-for-yourself) — 24 April 2023; the author's verified reading of the complete displayed official expanded text; direct opening returned InternalError. Feasible support rather than treatment by a relative. General rights for full commercial reproduction of sources remain UNKNOWN apart from the limited MHRA signal described above. Brief original attributed summaries are used, without copying complete documents, forms or images or bypassing access restrictions. ## Tags stopping medicine; shared decision; useful treatment; unwanted effects; individual support; physical adaptation; withdrawal symptoms; prescription review; access to a doctor; urgent help; consent; support from relatives ## About the authors Andrey Zarinsh is an author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue and contemporary spiritual discipline. Instagram: @andrey.zarinsh. Maria Evilkut is a coauthor of United Wisdom. Alongside her research, she seeks to test these ideas in practice and observe how principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.